Table 3.
Bone geometry and volumetric mineral density of the tibial diaphysis in children with nephrotic syndrome in comparison to healthy controls (mean ± SD).
Nephrotic syndrome | Healthy controls | P value | Adjusted p value | ||
---|---|---|---|---|---|
Model 1 | Model 2 | ||||
N | 29 | 29 | |||
Total BMC (mg/mm) | 264.4 ± 75.8 | 246.4 ± 70.6 | 0.35 | 0.033 | 0.28 |
Total vBMD (mg/cm3) | 503.7 ± 85.7 | 551.9 ± 86.1 | 0.037 | 0.045 | 0.14 |
Total bone CSA (mm2) | 534.9 ± 162.7 | 463.2 ± 155.5 | 0.09 | 0.014 | 0.13 |
Cortical vBMD (mg/cm3) | 1025.6 ± 57.3 | 1016.0 ± 68.6 | 0.57 | 0.60 | 0.18 |
Periosteal circumference (mm) | 81.1 ± 12.4 | 75.4 ± 12.1 | 0.082 | 0.010 | 0.099 |
Endosteal circumference (mm) | 65.8 ± 13.3 | 57.5 ± 12.7 | 0.018 | 0.007 | 0.058 |
Cortical CSA (mm2) | 176.8 ± 57.9 | 187.6 ± 51.2 | 0.46 | 0.22 | 0.18 |
Cortical thickness (mm) | 2.4 ± 0.7 | 2.8 ± 0.7 | 0.032 | 0.018 | 0.060 |
Muscle CSA (cm2) | 40.7 ± 1.4 | 38.1 ± 1.3 | 0.39 | 0.15 | 0.96 |
BMC:muscle CSA | 6.2 ± 1.2 | 6.2 ± 1.3 | 0.92 | 0.34 | 0.26 |
Model 1: Adjusted for age, gender, ethnicity, tanner stage and height.
Model 2: Adjusted for age, gender, ethnicity, tanner stage, height and weight.